Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Kenneth Siu Ho Chok T Yau |
| Publication date | January 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |